The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)
 
Sibylle Loibl
No Relationships to Disclose
 
Terry Hyslop
Consulting or Advisory Role - AstraZeneca
 
Juan de la Haba-Rodriguez
No Relationships to Disclose
 
Bahriye Aktas
No Relationships to Disclose
 
Constance Cirrincione
No Relationships to Disclose
 
Eva Maria Carrasco
Stock and Other Ownership Interests - Lilly
Consulting or Advisory Role - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche Pharma AG (I)
Speakers' Bureau - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche Pharma AG (I)
Research Funding - AstraZeneca Spain (Inst); AstraZeneca Spain (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genomic Health (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PAM 50 taxane predictor
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche
 
Keyur Mehta
No Relationships to Disclose
 
William Thomas Barry
Consulting or Advisory Role - ARMO BioSciences
Research Funding - Pfizer (Inst)
 
Serafin Morales
No Relationships to Disclose
 
Lisa A. Carey
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
 
Jose Angel Garcia Saenz
No Relationships to Disclose
 
Ann Partridge
No Relationships to Disclose
 
Noelia Martinez
No Relationships to Disclose
 
Olwen Mary Hahn
Honoraria - Cardinal Health (I)
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Eric P. Winer
Consulting or Advisory Role - Tesaro
Research Funding - Genentech
 
Angel Guerrero
No Relationships to Disclose
 
Cliff Hudis
Consulting or Advisory Role - Lilly; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Celgene; Covidien; Merck
Other Relationship - ASCO
 
Maribel Casas
No Relationships to Disclose
 
Maura N. Dickler
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; Merrimack; Novartis; Pfizer; Puma Biotechnology; Syndax; TapImmune Inc.
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst)